ORBIMED ADVISORS LLC Q2 2022 Filing
Filed August 15, 2022
Portfolio Value
$5.5B
Holdings
139
Report Date
Q2 2022
Filing Type
13F-HR
All Holdings (139 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 101 | AVTEAEROVATE THERAPEUTICS INC | 478,579 | $7.5B | 135.54% | |
| 102 | GLTOUSDGALECTO INC | 4,090,937 | $7.1B | 128.23% | |
| 103 | —SYNLOGIC INC | 6,029,995 | $6.9B | 125.64% | |
| 104 | CRVSCORVUS PHARMACEUTICALS INC | 6,943,654 | $6.9B | 124.57% | |
| 105 | LUNGPULMONX CORP | 435,000 | $6.4B | 116.02% | |
| 106 | SRRKSCHOLAR ROCK HLDG CORP | 1,076,540 | $5.9B | 107.09% | |
| 107 | CYBNEURCYBIN INC | 10,524,300 | $5.9B | 106.65% | |
| 108 | —HARPOON THERAPEUTICS INC | 3,039,508 | $5.8B | 105.19% | |
| 109 | MIRMMIRUM PHARMACEUTICALS INC | 279,500 | $5.4B | 98.55% | |
| 110 | —IMARA INC | 4,386,568 | $5.4B | 96.98% | |
| 111 | IMCRIMMUNOCORE HLDGS PLC | 131,100 | $4.9B | 88.62% | |
| 112 | NSTG 2.625 03/01/25NANOSTRING TECHNOLOGIES INC | 6,000,000 | $4.9B | 87.90% | |
| 113 | —GRAYBUG VISION INC | 4,163,347 | $4.5B | 82.23% | |
| 114 | VORVOR BIOPHARMA INC | 833,333 | $4.1B | 75.05% | |
| 115 | BNRBURNING ROCK BIOTECH LTD | 1,389,802 | $4.0B | 73.28% | |
| 116 | APLTAPPLIED THERAPEUTICS INC | 4,250,000 | $4.0B | 73.02% | |
| 117 | 698ACHILLES THERAPEUTICS PLC | 1,584,845 | $4.0B | 72.37% | |
| 118 | CTMXCYTOMX THERAPEUTICS INC | 2,124,975 | $3.9B | 70.47% | |
| 119 | NVV1NOVAVAX INC | 75,000 | $3.9B | 69.89% | Call |
| 120 | TCE2CELLDEX THERAPEUTICS INC NEW | 112,700 | $3.0B | 55.05% | |
| 121 | —LOGICBIO THERAPEUTICS INC | 8,466,783 | $3.0B | 53.76% | |
| 122 | AFIBACUTUS MED INC | 2,648,386 | $3.0B | 53.74% | |
| 123 | —MAGENTA THERAPEUTICS INC | 2,250,953 | $2.7B | 48.94% | |
| 124 | —ONCOCYTE CORP | 2,837,800 | $2.6B | 46.26% | |
| 125 | TARAPROTARA THERAPEUTICS INC | 830,641 | $2.4B | 44.10% | |
| 126 | GRPHGRAPHITE BIO INC | 848,412 | $2.3B | 42.27% | |
| 127 | —9 METERS BIOPHARMA INC | 8,505,729 | $2.2B | 40.19% | |
| 128 | —SINGULAR GENOMICS SYSTEMS IN | 540,697 | $2.1B | 37.42% | |
| 129 | PHGEBIOMX INC | 2,813,489 | $2.1B | 37.22% | |
| 130 | KALVKALVISTA PHARMACEUTICALS INC | 185,400 | $1.8B | 33.05% | |
| 131 | SGHTSIGHT SCIENCES INC | 200,000 | $1.8B | 32.58% | |
| 132 | EYPTEYEPOINT PHARMACEUTICALS INC | 214,100 | $1.7B | 30.53% | |
| 133 | SRPTSAREPTA THERAPEUTICS INC | 20,000 | $1.5B | 27.16% | |
| 134 | ASNSUSDX4 PHARMACEUTICALS INC | 1,373,849 | $1.3B | 24.03% | |
| 135 | —SONENDO INC | 723,478 | $1.2B | 22.54% | |
| 136 | —TALARIS THERAPEUTICS INC | 235,995 | $1.1B | 19.28% | |
| 137 | VIGLVIGIL NEUROSCIENCE INC | 411,191 | $1.1B | 19.23% | |
| 138 | AGLEUSDAEGLEA BIOTHERAPEUTICS INC | 1,797,221 | $908.0M | 16.45% | |
| 139 | —LONGBOARD PHARMACEUTICALS IN | 113,500 | $351.0M | 6.36% | |
| 140 | —APTINYX INC | 538,500 | $300.0M | 5.44% |
PreviousPage 2 of 2